4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-013334
General Counsel acquired 23,256 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Miller Edward · General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-18 | Grant or award : show line 1 in the form | +23,256 | 217,307 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-01-18 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +56,744 | $9.15 | 2032-01-18 | 56,744 | 56,744 | D |
Loading xslF345X03/doc4.xml…